Associations between β-Blocker Therapy at Discharge and Long-Term Follow-Up Outcomes in Patients with Unstable Angina Pectoris

Background. The effects of β-blockers in patients with unstable angina pectoris (UAP) are unclear. We tried to evaluate associations between β-blockers in UAP and long-term outcomes. Methods. We enrolled 5591 UAP patients and divided them into 2 groups based on β-blockers at discharge: 3790 did β-bl...

Full description

Saved in:
Bibliographic Details
Main Authors: Lei Liu, Xiaosong Ding, Hui Chen, Weiping Li, Hongwei Li
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Cardiology Research and Practice
Online Access:http://dx.doi.org/10.1155/2022/5287566
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849693431282008064
author Lei Liu
Xiaosong Ding
Hui Chen
Weiping Li
Hongwei Li
author_facet Lei Liu
Xiaosong Ding
Hui Chen
Weiping Li
Hongwei Li
author_sort Lei Liu
collection DOAJ
description Background. The effects of β-blockers in patients with unstable angina pectoris (UAP) are unclear. We tried to evaluate associations between β-blockers in UAP and long-term outcomes. Methods. We enrolled 5591 UAP patients and divided them into 2 groups based on β-blockers at discharge: 3790 did β-blockers and 1801 did not used them. Propensity score matching at 1 : 1 was performed to select 1786 patients from each group. The primary endpoint was major adverse cardiac and cerebral events (MACCE) during the long-term follow-up period. Results. 67.8% of patients were on β-blockers at discharge; these patients were more likely to have CHD risk factors, lower ejection fraction, and severity of the coronary artery lesions. Over a median of 25.0 years, the incidence of MACCE was 25.5%. The risk was not significantly different between those on and those not on β-blocker treatment. The multivariate Cox regression analysis showed that no β-blocker use at discharge was not an independent risk factor for MACCE and sequence secondary endpoints. After propensity score matching, the results were similar. Conclusions. β-blocker use was not associated with lower MACCE and other secondary composite endpoints in long-term outcomes. This result adds to the increasing body of evidence that the routine prescription of β-blockers might not be indicated in patients with UAP. Trial registration had retrospectively registered.
format Article
id doaj-art-2d63434f81f145b982e687426f68f6ee
institution DOAJ
issn 2090-0597
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Cardiology Research and Practice
spelling doaj-art-2d63434f81f145b982e687426f68f6ee2025-08-20T03:20:25ZengWileyCardiology Research and Practice2090-05972022-01-01202210.1155/2022/5287566Associations between β-Blocker Therapy at Discharge and Long-Term Follow-Up Outcomes in Patients with Unstable Angina PectorisLei Liu0Xiaosong Ding1Hui Chen2Weiping Li3Hongwei Li4Department of CardiologyDepartment of CardiologyDepartment of CardiologyDepartment of CardiologyDepartment of CardiologyBackground. The effects of β-blockers in patients with unstable angina pectoris (UAP) are unclear. We tried to evaluate associations between β-blockers in UAP and long-term outcomes. Methods. We enrolled 5591 UAP patients and divided them into 2 groups based on β-blockers at discharge: 3790 did β-blockers and 1801 did not used them. Propensity score matching at 1 : 1 was performed to select 1786 patients from each group. The primary endpoint was major adverse cardiac and cerebral events (MACCE) during the long-term follow-up period. Results. 67.8% of patients were on β-blockers at discharge; these patients were more likely to have CHD risk factors, lower ejection fraction, and severity of the coronary artery lesions. Over a median of 25.0 years, the incidence of MACCE was 25.5%. The risk was not significantly different between those on and those not on β-blocker treatment. The multivariate Cox regression analysis showed that no β-blocker use at discharge was not an independent risk factor for MACCE and sequence secondary endpoints. After propensity score matching, the results were similar. Conclusions. β-blocker use was not associated with lower MACCE and other secondary composite endpoints in long-term outcomes. This result adds to the increasing body of evidence that the routine prescription of β-blockers might not be indicated in patients with UAP. Trial registration had retrospectively registered.http://dx.doi.org/10.1155/2022/5287566
spellingShingle Lei Liu
Xiaosong Ding
Hui Chen
Weiping Li
Hongwei Li
Associations between β-Blocker Therapy at Discharge and Long-Term Follow-Up Outcomes in Patients with Unstable Angina Pectoris
Cardiology Research and Practice
title Associations between β-Blocker Therapy at Discharge and Long-Term Follow-Up Outcomes in Patients with Unstable Angina Pectoris
title_full Associations between β-Blocker Therapy at Discharge and Long-Term Follow-Up Outcomes in Patients with Unstable Angina Pectoris
title_fullStr Associations between β-Blocker Therapy at Discharge and Long-Term Follow-Up Outcomes in Patients with Unstable Angina Pectoris
title_full_unstemmed Associations between β-Blocker Therapy at Discharge and Long-Term Follow-Up Outcomes in Patients with Unstable Angina Pectoris
title_short Associations between β-Blocker Therapy at Discharge and Long-Term Follow-Up Outcomes in Patients with Unstable Angina Pectoris
title_sort associations between β blocker therapy at discharge and long term follow up outcomes in patients with unstable angina pectoris
url http://dx.doi.org/10.1155/2022/5287566
work_keys_str_mv AT leiliu associationsbetweenbblockertherapyatdischargeandlongtermfollowupoutcomesinpatientswithunstableanginapectoris
AT xiaosongding associationsbetweenbblockertherapyatdischargeandlongtermfollowupoutcomesinpatientswithunstableanginapectoris
AT huichen associationsbetweenbblockertherapyatdischargeandlongtermfollowupoutcomesinpatientswithunstableanginapectoris
AT weipingli associationsbetweenbblockertherapyatdischargeandlongtermfollowupoutcomesinpatientswithunstableanginapectoris
AT hongweili associationsbetweenbblockertherapyatdischargeandlongtermfollowupoutcomesinpatientswithunstableanginapectoris